Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series

被引:32
作者
Achinger, Steven G. [1 ]
Arieff, Allen Israel [2 ]
Kalantar-Zadeh, Kamyar [3 ]
Ayus, Juan Carlos [4 ,5 ]
机构
[1] Watson Clin LLP, Dept Nephrol, Lakeland, FL USA
[2] Univ Calif San Francisco, Sch Med, San Francisco, CA USA
[3] Univ Calif Irvine, Irvine, CA USA
[4] Renal Consultants Houston, Houston, TX 77338 USA
[5] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
关键词
central pontine myelinolysis; DDAVP; desmopressin; hyponatremia; OSMOTIC MYELINOLYSIS; ENCEPHALOPATHY; VASOPRESSIN; DDAVP;
D O I
10.1093/ndt/gfu263
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Desmopressin (DDAVP) is typically prescribed for central diabetes insipidus, von Willebrands disease and for enuresis. DDAVP-associated hyponatremia is a known complication of DDAVP therapy. The currently recommended treatment for this condition calls for discontinuing DDAVP as part of the initial therapy. This recommendation could lead to a water diuresis and potentially over-correction of the serum sodium. The 15 patients in this case series developed symptomatic DDAVP-associated hyponatremia and were admitted to acute care hospitals. Thirty-eight percent presented with symptomatic hyponatremia and 62% developed symptomatic hyponatremia due to concomitant DDAVP and hypotonic intravenous fluid administration during a hospital stay. Group 1 patients (n = 13) were treated by withholding DDAVP and providing intravenous saline. Group 2 patients (n = 2) were treated by continuing DDAVP and providing DDAVP and intravenous hypertonic saline. Among Group 1 patients, in whom DDAVP was withheld as initial management of DDAVP-associated hyponatremia (n = 13), the mean change in serum sodium in the first 2 days of treatment was 37.1 +/- 8.1 mEq/L. The ultimate outcome in this group was death in 23%, severe brain damage in 69% and moderate brain damage in 8%. In Group 2 patients, in whom DDAVP was continued (n = 2) as part of the initial management strategy, the mean change in serum sodium was 11.0 +/- 0 mEq/L in the first 2 days. The ultimate outcome was survival without neurological sequelae in both cases. Discontinuing DDAVP in a patient with symptomatic DDAVP-associated hyponatremia can lead to rapid correction of the serum sodium and resultant severe neurological injury. In contrast, continuing the medication while correcting DDAVP-associated hyponatremia may lead to better outcomes by avoiding over-correction of the serum sodium. Thus, an alternative approach that we propose is to continue DDAVP as part of the initial management of this disorder.
引用
收藏
页码:2310 / 2315
页数:6
相关论文
共 12 条
[1]  
[Anonymous], MICR HEALTHC SER INT
[2]   TREATMENT OF SYMPTOMATIC HYPONATREMIA AND ITS RELATION TO BRAIN-DAMAGE - A PROSPECTIVE-STUDY [J].
AYUS, JC ;
KROTHAPALLI, RK ;
ARIEFF, AI .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (19) :1190-1195
[3]  
AYUS JC, 1993, ENDOCRIN METAB CLIN, V22, P425
[4]  
Ayus JC, 2005, NEW ENGL J MED, V353, P427
[5]   POSTOPERATIVE HYPONATREMIC ENCEPHALOPATHY IN MENSTRUANT WOMEN [J].
AYUS, JC ;
WHEELER, JM ;
ARIEFF, AI .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (11) :891-897
[6]   Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia [J].
Ayus, Juan Carlos ;
Achinger, Steven G. ;
Arieff, Allen .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 295 (03) :F619-F624
[7]  
Goldszmidt MA, 2000, CLIN NEPHROL, V53, P226
[8]   Osmotic myelinolysis syndrome after treatment of severe deamino arginine vasopressin-associated hyponatraemia: Pitfalls on emergency medicine [J].
Gutenstein, Marc .
EMERGENCY MEDICINE AUSTRALASIA, 2007, 19 (01) :68-70
[9]   Osmotic Myelinolysis with Malignant Cerebellar Edema Occurring after DDAVP-Induced Hyponatremia in a Child [J].
Ranger, Adrianna ;
Szymczak, Artur ;
Levin, Simon ;
Salvadori, Marina ;
Fraser, Douglas D. .
PEDIATRIC NEUROSURGERY, 2010, 46 (04) :318-323
[10]   Treating desmopressin-induced hyponatremia: a case using hypertonic saline [J].
Shirazian, Shayan ;
Ali, Nicole ;
Fishbane, Steven .
CLINICAL NEPHROLOGY, 2013, 80 (05) :385-387